Sareum Holdings (FRA:RYH0) Moat Score: 0/10 (As of Jul. 07, 2026)


FRA:RYH0 Sareum Holdings PLC FRA:RYH0
37 GF Score
Price €0.21
! 3 Warning Signs
View Full Analysis

What is Sareum Holdings Moat Score?

Sareum Holdings has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Sareum Holdings has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Sareum Holdings might have No Moat - No discernible moat.


Sareum Holdings  (FRA:RYH0) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Sareum Holdings Moat Score Related Terms

FRA:RYH0
37GF Score
Sareum Holdings PLC FRA:RYH0
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sareum Holdings Business Description

Other Exchanges SAR:UK
Address Langford Arch, London Road, Unit 2a, Pampisford, Cambridge, Cambridgeshire, GBR, CB22 3FX
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.
37GF Score

Get the complete analysis for FRA:RYH0

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.21
Price